Former Covid medical officer Van-Tam takes role at vaccine maker Moderna One of UK’s public faces of pandemic, ‘JVT’ was known for football-related metaphors in No 10 briefings The Guardian - UK · Aug 18, 2023
Covid booster jabs could go on sale privately in UK in 2024 Health officials reiterate support for private provision as lower age limit for NHS booster vaccines raised to 65 The Guardian - UK · Aug 17, 2023
Ex-medical chief Jonathan Van-Tam takes job with Covid vaccine giant Moderna Move may spark fresh questions over ‘revolving door’ between government and business The Independent UK · Aug 17, 2023
When Should You Get Your Next Covid-19 Booster? There’s One Easy Answer To This Question Vaccine manufacturers like Pfizer/BioNTech, Moderna, and Novavax are switching up their shots in preparation for the new season. Inverse · Aug 17, 2023
Covid vaccines should be available to buy privately in UK, scientists say People not eligible for autumn booster programme should have option to pay for jab, experts argue, amid new wave concerns The Guardian - UK · Aug 17, 2023
Coronavirus FAQ: Is it wiser to get a booster now or wait for the new fall booster? Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind. WEKU · Aug 11, 2023
For Flagship, Moderna’s COVID-19 vaccine is a tough act to follow Unorthodox, brash, and sometimes controversial, Flagship Pioneering is looking for its next blockbuster. Fortune · Aug 10, 2023
The Most Objective Evidence Shows No Indication That Covid Vaccines Save More Lives Than They Take Medical journals describe all-cause mortality in randomized controlled trials (RCTs) Zenger · Jul 30, 2023
FDA Violated Own Safety And Efficacy Standards In Approving Covid-19 Vaccines For Children Evidence the FDA used for those decisions violates at least three safety and efficacy standards from earlier FDA publications Zenger · Jul 28, 2023
Pfizer and Moderna parent are investing $100M to find the next big drug "What we are doing now, I don’t think anyone has done so far," Pfizer CEO Albert Bourla says. Fortune · Jul 25, 2023
Moderna signs deal to make mRNA vaccines for Chinese market Moderna Inc. will push toward producing messenger RNA vaccines for China, seeking a foothold in the world’s second-largest pharmaceutical market even as geopolitical tensions rise. Tribune News Service · Jul 6, 2023
A Long-Awaited Vaccine For Lyme Disease is Tantalizingly Close — Here's When It Could Be Available Over the past twenty years, Lyme disease cases have continued to climb, and we are finally tantalizingly close to another vaccine. Inverse · Jul 5, 2023
UK regulator sued for not investigating Covid vaccine ‘misinformation’ Case brought against General Medical Council for failure to look into claimed links to heart problems and deaths The Guardian - UK · Jul 4, 2023
Health care providers are adding cloud tech, but need to dream bigger Currently, the application of cloud in the health care space is choppy. Fortune · Jun 30, 2023
Fortune · Jun 26, 2023 Cancer vaccines are already a reality. Here's what you need to know about the cutting-edge technology that could usher in an era of personalized medicine The concept may seem torn from the plot of some futuristic sci-fi movie, or from the pages of some decades-old utopian novel far ahead of its time. But such wonders of science exist today.
Zenger · Jun 26, 2023 Moderna Stock Rises After FDA Application For Updated Vaccine Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy
StockNews.com · Jun 21, 2023 Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Should You Be Investing In? Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, Moderna (MRNA) and BioNTech (BNTX), is a more favorable investment choice in the current uncertain economic climate. Keep reading to find out.
Inverse · Jun 18, 2023 mRNA Vaccines Could Revolutionize Cancer Treatment Here’s a look at the status of mRNA technology's application in cancer and when it might reach patients.
Wales Online · Jun 11, 2023 Devastating virus few parents know about hits three babies a day World-first vaccine trials have now begun in a bid to protect children from CMV
Insider UK · May 17, 2023 Scottish Mortgage sees share price fall by a third Net asset value also fell by more than 17% during a year that has been 'painful for shareholders'
Inverse · May 15, 2023 These Next-Generation Vaccines Could Upend Cancer Treatment As We Know It New high-tech vaccines could help combat common yet deadly conditions like cancer and heart disease.
The Walrus · May 15, 2023 The Vaccine Problem To better weather future pandemics, the way countries procure vaccines needs to change radically
The New Daily · May 10, 2023 mRNA technology beat COVID-19, can it do the same for pancreatic cancer? Half the pancreatic cancer patients in a new clinical trial were alive and cancer free after 18 months. Most usually die within three months.
The Hindu · May 6, 2023 FDA approves first vaccine for respiratory syncytial virus The FDA has approved the first vaccine for respiratory syncytial virus (RSV).
Kiplinger · May 4, 2023 Moderna Stock Pops on Surprise Earnings Beat An unexpected profit and promising news on a deal with the EU boosted Moderna stock.